Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition | Drug Metabolism & Disposition
Small molecule inhibitors of histone acetyltransferases and deacetylases are potential drugs for inflammatory diseases - ScienceDirect
Frontiers | Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease | Cell and Developmental Biology
Effects of HDAC inhibitors in cancer cells. In healthy cells, promoters... | Download Scientific Diagram
Frontiers | Histone Deacetylase Inhibitors as Therapeutic Interventions on Cervical Cancer Induced by Human Papillomavirus | Cell and Developmental Biology
Histone acetyltransferases: challenges in targeting bi-substrate enzymes | Clinical Epigenetics | Full Text
Figure 1 | Targeting epigenetics for cancer therapy | SpringerLink
CPTH2 is a Potent Histone Acetyltransferase (HAT) Inhibitor - Network of Cancer Research
Characterization of novel inhibitors of histone acetyltransferases | Molecular Cancer Therapeutics
Targeted cancer therapy: giving histone deacetylase inhibitors all they need to succeed | Future Medicinal Chemistry
The role of histone deacetylases (HDACs) in human cancer - Ropero - 2007 - Molecular Oncology - Wiley Online Library
Known HAt inhibitors | Download Table
KATs in cancer: functions and therapies | Oncogene
Gururaj M. Shivashimpi's Blog: Histone Deacetylase Inhibition and Cancer Therapy
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials | Signal Transduction and Targeted Therapy
Inhibition of histone acetyltransferase GCN5 extends lifespan in both yeast and human cell lines - Huang - 2020 - Aging Cell - Wiley Online Library
HAT inhibitors in cancer therapy - ScienceDirect
Rational Combinations Using HDAC Inhibitors | Clinical Cancer Research
Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer | Anticancer Research
HAT inhibitors in cancer therapy - ScienceDirect
Cureus | Advances in Epigenetic Cancer Therapeutics
Histone acetyltransferase (HAT) activation as a therapeutic strategy.... | Download Scientific Diagram
